Pfizer and BioNTech have announced that they would seek the FDA's approval for the third dose of their COVID-19 vaccine to boost its efficacy, as the Delta variant is increasingly becoming a global dominant.

Pfizer-BioNTech to seek FDA approval for third dose of COVID-19 vaccine

BioNTech founder 'confident' its Covid vaccine willl work against strain first found in India

WHO recordings show China delayed releasing coronavirus information

WHO says Pfizer's vaccine safe to use as concerns rise post-Norway deaths

Pfizer-BioNTech's vaccine raised hopes, but supply, efficacy concerns are hurting

Took steps to accelerate COVID-19 vaccine process without shortcuts: German firm BioNTech

The new COVID vaccine being developed by Pfizer and BioNTech would begin to be delivered at the "end of this year, beginning of next year" if everything continued to go well, one of its creators said on Sunday.

Ray of hope in COVID-19 wrecked world; Biontech co-founder shows hope of normalcy

'World cannot put all eggs in one basket': WHO chief Tedros 'encouraged' by coronavirus clinical trials

The US and Europe are in line to get the first doses of an experimental coronavirus vaccine after a partnership between Pfizer Inc. and BioNTech SE delivered dazzling preliminary results in a large patient trial.

Countries queue for Pfizer's COVID-19 vaccine

U.S. infectious disease expert Anthony Fauci said on Thursday vaccine developers should push to make billions of their COVID-19 vaccines to ensure access to all parts of the world, instead of focusing on the rich countries.

Fauci hopeful about the prospects for a successful COVID-19 vaccine